LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC
2023 · JTO Clinical and Research Reports · 9 citations
https://doi.org/10.1016/j.jtocrr.2023.100490
J
Joe Wei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
232
Citations
9
h-index
8
i10-index
Joe Wei is an academic researcher from University of Sydney. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations. The author has an h-index of 9, co-authored 33 publications.
ORCID: 0000-0003-1944-1079Papers by this author
worksPathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study
2025 · British journal of surgery · 7 citations
https://doi.org/10.1093/bjs/znaf056
Clinical outcomes and management of <i>CDKN2A/B</i> homozygously deleted IDH-mutant astrocytomas—a cohort study and patterns of care survey
2025 · Neuro-Oncology Practice · 2 citations
https://doi.org/10.1093/nop/npaf045
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours
2025 · Journal of Neuro-Oncology · 1 citations
https://doi.org/10.1007/s11060-025-05258-9
A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions – a retrospective cohort review
2025 · Cancer Treatment and Research Communications · 0 citations
https://doi.org/10.1016/j.ctarc.2025.100969
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat